Encouraged by the superior tumor retention and ICD phenomenon, we subsequently evaluated the antitumor efficacy of anti‐PD‐L1‐DOX‐R848‐MIP‐3α/TKNP following intratumoral injection for 20 days (Figure 5e). Here, CCL20 is linked to neoplasm.